SPPI Annual EBITDA
-$77.06 M
+$70.36 M+47.73%
31 December 2022
Summary:
As of February 5, 2025, SPPI annual earnings before interest, taxes, depreciation & amortization is -$77.06 million, with the most recent change of +$70.36 million (+47.73%) on December 31, 2022. During the last 3 years, it has risen by +$62.02 million (+44.59%).SPPI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPPI Quarterly EBITDA
-$4.06 M
+$11.90 M+74.54%
31 March 2023
Summary:
As of February 5, 2025, SPPI quarterly earnings before interest, taxes, depreciation & amortization is -$4.06 million, with the most recent change of +$11.90 million (+74.54%) on March 31, 2023. Over the past year, it has increased by +$9.93 million (+70.96%).SPPI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPPI TTM EBITDA
-$66.89 M
+$9.93 M+12.92%
31 March 2023
Summary:
As of February 5, 2025, SPPI TTM earnings before interest, taxes, depreciation & amortization is -$66.89 million, with the most recent change of +$9.93 million (+12.92%) on March 31, 2023. Over the past year, it has increased by +$71.58 million (+51.69%).SPPI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPPI EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.7% | +71.0% | +51.7% |
| 3 y3 years | +44.6% | +86.7% | +49.8% |
| 5 y5 years | +12.4% | +68.8% | +51.8% |
SPPI EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -183.2% | -115.8% | -172.2% |
Spectrum Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$4.06 M(-74.5%) | -$66.89 M(-12.9%) |
| Dec 2022 | -$77.06 M(-47.7%) | -$15.96 M(-25.9%) | -$76.81 M(-29.1%) |
| Sept 2022 | - | -$21.55 M(-14.9%) | -$108.31 M(-9.6%) |
| June 2022 | - | -$25.32 M(+81.0%) | -$119.78 M(-13.5%) |
| Mar 2022 | - | -$13.99 M(-70.5%) | -$138.46 M(-12.4%) |
| Dec 2021 | -$147.42 M(-13.0%) | -$47.46 M(+43.7%) | -$158.09 M(-8.7%) |
| Sept 2021 | - | -$33.02 M(-25.0%) | -$173.16 M(-3.6%) |
| June 2021 | - | -$44.00 M(+30.9%) | -$179.71 M(+4.4%) |
| Mar 2021 | - | -$33.62 M(-46.2%) | -$172.06 M(+1.8%) |
| Dec 2020 | -$169.47 M(+21.9%) | -$62.52 M(+58.0%) | -$169.09 M(+16.8%) |
| Sept 2020 | - | -$39.57 M(+8.9%) | -$144.79 M(+6.9%) |
| June 2020 | - | -$36.35 M(+18.6%) | -$135.42 M(+1.6%) |
| Mar 2020 | - | -$30.65 M(-19.8%) | -$133.29 M(-3.9%) |
| Dec 2019 | -$139.08 M(+39.3%) | -$38.22 M(+26.5%) | -$138.64 M(+6.7%) |
| Sept 2019 | - | -$30.21 M(-11.7%) | -$129.88 M(+7.3%) |
| June 2019 | - | -$34.21 M(-5.0%) | -$121.09 M(+88.1%) |
| Mar 2019 | - | -$36.00 M(+22.2%) | -$64.38 M(+55.5%) |
| Dec 2018 | -$99.86 M(+13.6%) | -$29.47 M(+37.6%) | -$41.39 M(-34.2%) |
| Sept 2018 | - | -$21.41 M(-195.2%) | -$62.91 M(+20.4%) |
| June 2018 | - | $22.50 M(-272.9%) | -$52.23 M(-39.4%) |
| Mar 2018 | - | -$13.01 M(-74.5%) | -$86.22 M(-1.9%) |
| Dec 2017 | -$87.92 M(+143.2%) | -$50.98 M(+374.6%) | -$87.92 M(+83.3%) |
| Sept 2017 | - | -$10.74 M(-6.5%) | -$47.97 M(+4.8%) |
| June 2017 | - | -$11.49 M(-21.9%) | -$45.77 M(-8.2%) |
| Mar 2017 | - | -$14.71 M(+33.4%) | -$49.83 M(+37.8%) |
| Dec 2016 | -$36.16 M(+646.6%) | -$11.03 M(+29.3%) | -$36.16 M(+102.9%) |
| Sept 2016 | - | -$8.53 M(-45.1%) | -$17.82 M(-4.8%) |
| June 2016 | - | -$15.55 M(+1397.0%) | -$18.71 M(-586.3%) |
| Mar 2016 | - | -$1.04 M(-114.2%) | $3.85 M(-189.7%) |
| Dec 2015 | -$4.84 M(-49.5%) | $7.31 M(-177.6%) | -$4.29 M(-26.1%) |
| Sept 2015 | - | -$9.42 M(-234.6%) | -$5.80 M(-216.8%) |
| June 2015 | - | $7.00 M(-176.3%) | $4.96 M(+289.6%) |
| Mar 2015 | - | -$9.17 M(-258.3%) | $1.27 M(-114.0%) |
| Dec 2014 | -$9.60 M(-22.3%) | $5.80 M(+332.2%) | -$9.07 M(-24.4%) |
| Sept 2014 | - | $1.34 M(-59.5%) | -$11.99 M(-39.4%) |
| June 2014 | - | $3.31 M(-117.0%) | -$19.77 M(-33.9%) |
| Mar 2014 | - | -$19.52 M(-779.5%) | -$29.93 M(+140.9%) |
| Dec 2013 | -$12.35 M(-113.3%) | $2.87 M(-144.6%) | -$12.42 M(-1454.6%) |
| Sept 2013 | - | -$6.44 M(-5.9%) | $917.00 K(-97.2%) |
| June 2013 | - | -$6.85 M(+240.9%) | $33.14 M(-49.3%) |
| Mar 2013 | - | -$2.01 M(-112.4%) | $65.39 M(-29.4%) |
| Dec 2012 | $92.66 M(+49.0%) | $16.21 M(-37.1%) | $92.66 M(+3.9%) |
| Sept 2012 | - | $25.78 M(+1.5%) | $89.18 M(+7.5%) |
| June 2012 | - | $25.40 M(+0.6%) | $82.96 M(+20.6%) |
| Mar 2012 | - | $25.26 M(+98.4%) | $68.80 M(+10.6%) |
| Dec 2011 | $62.20 M(-233.4%) | $12.73 M(-34.9%) | $62.20 M(+5.1%) |
| Sept 2011 | - | $19.56 M(+74.0%) | $59.17 M(+74.5%) |
| June 2011 | - | $11.24 M(-39.7%) | $33.91 M(+195.5%) |
| Mar 2011 | - | $18.66 M(+92.2%) | $11.48 M(-124.6%) |
| Dec 2010 | -$46.61 M(+92.1%) | $9.71 M(-270.4%) | -$46.61 M(-27.9%) |
| Sept 2010 | - | -$5.70 M(-49.1%) | -$64.61 M(-3.0%) |
| June 2010 | - | -$11.19 M(-71.6%) | -$66.61 M(+5.4%) |
| Mar 2010 | - | -$39.43 M(+375.4%) | -$63.20 M(+169.5%) |
| Dec 2009 | -$24.26 M | -$8.29 M(+7.8%) | -$23.45 M(+7.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2009 | - | -$7.69 M(-1.3%) | -$21.80 M(-6.0%) |
| June 2009 | - | -$7.79 M(-2504.0%) | -$23.20 M(+403.0%) |
| Mar 2009 | - | $324.00 K(-104.9%) | -$4.61 M(-66.6%) |
| Dec 2008 | -$13.86 M(-62.5%) | -$6.64 M(-27.0%) | -$13.82 M(-32.8%) |
| Sept 2008 | - | -$9.09 M(-184.2%) | -$20.56 M(+31.7%) |
| June 2008 | - | $10.80 M(-221.6%) | -$15.62 M(-53.2%) |
| Mar 2008 | - | -$8.88 M(-33.7%) | -$33.37 M(+1.4%) |
| Dec 2007 | -$36.94 M(+43.8%) | -$13.38 M(+222.6%) | -$32.91 M(+55.4%) |
| Sept 2007 | - | -$4.15 M(-40.4%) | -$21.18 M(-4.0%) |
| June 2007 | - | -$6.96 M(-17.4%) | -$22.05 M(-11.0%) |
| Mar 2007 | - | -$8.42 M(+410.7%) | -$24.77 M(+15.6%) |
| Dec 2006 | -$25.70 M(+33.5%) | -$1.65 M(-67.2%) | -$21.42 M(-9.4%) |
| Sept 2006 | - | -$5.02 M(-48.1%) | -$23.65 M(-1.0%) |
| June 2006 | - | -$9.68 M(+90.8%) | -$23.89 M(+26.1%) |
| Mar 2006 | - | -$5.07 M(+30.6%) | -$18.96 M(-1.5%) |
| Dec 2005 | -$19.24 M(+55.5%) | -$3.88 M(-26.3%) | -$19.24 M(+1.3%) |
| Sept 2005 | - | -$5.27 M(+11.2%) | -$18.99 M(+6.4%) |
| June 2005 | - | -$4.74 M(-11.5%) | -$17.85 M(+14.2%) |
| Mar 2005 | - | -$5.35 M(+47.6%) | -$15.63 M(+26.3%) |
| Dec 2004 | -$12.38 M(+24.3%) | -$3.63 M(-12.2%) | -$12.38 M(-4.9%) |
| Sept 2004 | - | -$4.13 M(+63.7%) | -$13.02 M(+14.1%) |
| June 2004 | - | -$2.52 M(+20.5%) | -$11.41 M(+8.9%) |
| Mar 2004 | - | -$2.09 M(-51.0%) | -$10.48 M(+4.8%) |
| Dec 2003 | -$9.96 M(-24.1%) | -$4.27 M(+69.2%) | -$9.99 M(+35.0%) |
| Sept 2003 | - | -$2.52 M(+59.2%) | -$7.40 M(+30.0%) |
| June 2003 | - | -$1.59 M(-1.5%) | -$5.69 M(-35.2%) |
| Mar 2003 | - | -$1.61 M(-4.2%) | -$8.79 M(-33.0%) |
| Dec 2002 | -$13.13 M(-49.3%) | -$1.68 M(+106.2%) | -$13.13 M(-32.2%) |
| Sept 2002 | - | -$815.50 K(-82.6%) | -$19.35 M(-21.1%) |
| June 2002 | - | -$4.69 M(-21.2%) | -$24.53 M(-7.1%) |
| Mar 2002 | - | -$5.95 M(-24.8%) | -$26.39 M(+2.0%) |
| Dec 2001 | -$25.88 M(-38.3%) | -$7.91 M(+31.9%) | -$25.88 M(-11.5%) |
| Sept 2001 | - | -$5.99 M(-8.4%) | -$29.23 M(-15.0%) |
| June 2001 | - | -$6.55 M(+20.5%) | -$34.38 M(-9.7%) |
| Mar 2001 | - | -$5.43 M(-51.7%) | -$38.07 M(-9.3%) |
| Dec 2000 | -$41.98 M(+82.5%) | -$11.25 M(+0.9%) | -$41.95 M(+4.1%) |
| Sept 2000 | - | -$11.15 M(+9.0%) | -$40.30 M(+17.3%) |
| June 2000 | - | -$10.23 M(+9.8%) | -$34.35 M(+23.0%) |
| Mar 2000 | - | -$9.32 M(-3.0%) | -$27.92 M(+21.9%) |
| Dec 1999 | -$23.00 M(+107.2%) | -$9.60 M(+84.7%) | -$22.90 M(+37.1%) |
| Sept 1999 | - | -$5.20 M(+36.8%) | -$16.70 M(+16.0%) |
| June 1999 | - | -$3.80 M(-11.6%) | -$14.40 M(+9.9%) |
| Mar 1999 | - | -$4.30 M(+26.5%) | -$13.10 M(+19.1%) |
| Dec 1998 | -$11.10 M(+68.2%) | -$3.40 M(+17.2%) | -$11.00 M(+11.1%) |
| Sept 1998 | - | -$2.90 M(+16.0%) | -$9.90 M(+11.2%) |
| June 1998 | - | -$2.50 M(+13.6%) | -$8.90 M(+15.6%) |
| Mar 1998 | - | -$2.20 M(-4.3%) | -$7.70 M(+18.5%) |
| Dec 1997 | -$6.60 M(+450.0%) | -$2.30 M(+21.1%) | -$6.50 M(+30.0%) |
| Sept 1997 | - | -$1.90 M(+46.2%) | -$5.00 M(+51.5%) |
| June 1997 | - | -$1.30 M(+30.0%) | -$3.30 M(+73.7%) |
| Mar 1997 | - | -$1.00 M(+25.0%) | -$1.90 M(+137.5%) |
| Dec 1996 | -$1.20 M | -$800.00 K(+300.0%) | -$800.00 K(<-9900.0%) |
| Sept 1996 | - | -$200.00 K(-300.0%) | $0.00(-100.0%) |
| June 1996 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Mar 1996 | - | $100.00 K | $100.00 K |
FAQ
- What is Spectrum Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals annual EBITDA year-on-year change?
- What is Spectrum Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Spectrum Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for Spectrum Pharmaceuticals?
- What is Spectrum Pharmaceuticals TTM EBITDA year-on-year change?
What is Spectrum Pharmaceuticals annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of SPPI is -$77.06 M
What is the all time high annual EBITDA for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high annual earnings before interest, taxes, depreciation & amortization is $92.66 M
What is Spectrum Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, SPPI annual earnings before interest, taxes, depreciation & amortization has changed by +$70.36 M (+47.73%)
What is Spectrum Pharmaceuticals quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of SPPI is -$4.06 M
What is the all time high quarterly EBITDA for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high quarterly earnings before interest, taxes, depreciation & amortization is $25.78 M
What is Spectrum Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, SPPI quarterly earnings before interest, taxes, depreciation & amortization has changed by +$9.93 M (+70.96%)
What is Spectrum Pharmaceuticals TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of SPPI is -$66.89 M
What is the all time high TTM EBITDA for Spectrum Pharmaceuticals?
Spectrum Pharmaceuticals all-time high TTM earnings before interest, taxes, depreciation & amortization is $92.66 M
What is Spectrum Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, SPPI TTM earnings before interest, taxes, depreciation & amortization has changed by +$71.58 M (+51.69%)